Studies using the same protocol with other cell types, including human PPGL cell lines or primary tumor cells, which carry pathogenic RET variants or do not carry cluster 2-related gene mutations such as RET or MAX, should be performed to elucidate the influence of genetic background on the significance of RET signaling inhibition in relation to abnormal catecholamine production in PPGLs. This evidence concerns the gene MAX and neoplasm.